0 items USD 0.00Search
Your search for "Pharma Pipeline" gave back 126 results.
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
颁补迟补濒辞驳:听
La Merie Publishing
June 2022
Price: USD 1,170.00
鈥淣onalcoholic steatohepatitis (NASH) Pipeline Analysis鈥� gives comprehensive insight on the various drugs being developed for the treatment of NASH...
颁补迟补濒辞驳:听
IQ4I
July 2015
Price: USD 3,600.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research鈥檚 latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
EGF-R Antibodies 鈥揃iosimilars and Biosuperiors The present Competitive Intelligence Report about EGF-R Antibodies 鈥揃iosimilars and Biosuperiors...
颁补迟补濒辞驳:听
La Merie Publishing
March 2014
Price: USD 344.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
颁补迟补濒辞驳:听
La Merie Publishing
November 2016
Price: USD 225.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
颁补迟补濒辞驳:听
CBR Pharma Insights
July 2015
Price: USD 2,995.00
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 225.00
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 225.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
颁补迟补濒辞驳:听
La Merie Publishing
July 2022
Price: USD 2,000.00
CD123-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 225.00
The Competitive Intelligence Report Cardiometabolic Peptides as of November 2014 provides a competitor analysis in the development pipeline of...
颁补迟补濒辞驳:听
La Merie Publishing
November 2014
Price: USD 499.00
The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development...
颁补迟补濒辞驳:听
La Merie Publishing
November 2014
Price: USD 499.00
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis...
颁补迟补濒辞驳:听
La Merie Publishing
November 2014
Price: USD 381.00
This Competitive Intelligence report about Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS provides a competitor evaluation...
颁补迟补濒辞驳:听
La Merie Publishing
November 2016
Price: USD 560.00
Competitor Analysis: PD-1 and PD-L1 Immune Checkpoint Inhibitors 2016 This Competitive Intelligence report about PD-1 and PD-L1 Immune Checkpoint...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 450.00
听
